Atazanavir Sulfate [atazanavir sulfát]
- Terms
 - 
            
atazanavir
Evotaz
Reyataz 
- 
            
3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-((4-(2-pyridinyl)phenyl)methyl)-2,5,6,10,13-pentaazatetradecanedioic acid dimethyl ester
Atazanavir
BMS 232632
BMS-232632
BMS-232632-05
BMS232632
CGP 73547
CGP 75136
CGP 75176
CGP 75355
CGP-73547
CGP-75136
CGP-75176
CGP-75355
CGP75136
CGP75176
CGP75355
Reyataz 
An azapeptide and HIV-PROTEASE INHIBITOR that is used in the treatment of HIV INFECTIONS and AIDS in combination with other ANTI-HIV AGENTS.
- DUI
 - D000069446 MeSH Browser
 - CUI
 - M0445555
 - History note
 - 2016 (2000)
 - Public note
 - 2016; ATAZANAVIR SULFATE was indexed under OLIGOPEPTIDES and PYRIDINES 2000-2015
 
Allowable subheadings
- AD
 - administration & dosage
 - AE
 - adverse effects 1
 - AG
 - agonists
 - AA
 - analogs & derivatives
 - AN
 - analysis
 - AI
 - antagonists & inhibitors
 - BL
 - blood
 - CF
 - cerebrospinal fluid
 - CS
 - chemical synthesis
 - CH
 - chemistry 1
 - CL
 - classification
 - EC
 - economics
 - HI
 - history
 - IM
 - immunology
 - IP
 - isolation & purification
 - ME
 - metabolism
 - PK
 - pharmacokinetics 1
 - PD
 - pharmacology 3
 - PO
 - poisoning
 - RE
 - radiation effects
 - ST
 - standards
 - SD
 - supply & distribution
 - TU
 - therapeutic use
 - TO
 - toxicity
 - UR
 - urine
 
atazanavir, ritonavir drug combination Chemical MeSH Browser